Dr. Joanna Horobin - 17 Oct 2022 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
17 Oct 2022
Net transactions value
$0
Form type
4
Filing time
19 Oct 2022, 09:00:33 UTC
Previous filing
29 Jul 2022
Next filing
19 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award +14,285 +22% 77,994 17 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On October 17, 2022, the Reporting Person was granted 14,285 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date.